-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
SpringWorks Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- SpringWorks Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$44.9M, a 45.8% increase year-over-year.
- SpringWorks Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$321M, a 3.4% decline year-over-year.
- SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$343M, a 22.2% decline from 2022.
- SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$281M, a 61.8% decline from 2021.
- SpringWorks Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$173M, a 274% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)